lCombination therapy is
now recommended.
lMonitor disease
progression by measuring HIV RNA and CD4 counts.
lResistance develops
very quickly.
lDrug interactions
should be taken into consideration.
lCompliance should be
monitored.
lTherapy should be
initiated early.